1. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
    Alimuddin Zumla et al, 2016, BMC Med CrossRef
  2. Poly(N-(2-hydroxypropyl)methacrylamide)–valproic acid conjugates as block copolymer nanocarriers
    Jawaher A. Alfurhood et al, 2017, Polym. Chem. CrossRef
  3. Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
    XIUJUN HAN et al, 2015 CrossRef
  4. Treatment with a JNK inhibitor increases, whereas treatment with a p38 inhibitor decreases, H2O2-induced calf pulmonary arterial endothelial cell death
    Woo Hyun Park, 2017 CrossRef
  5. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells
    Subbroto Saha et al, 2017, IJMS CrossRef
  6. Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis
    Martin Rao et al, 2018, International Journal of Infectious Diseases CrossRef
  7. Novel Poly (ADP-Ribose) Polymerase Inhibitor AZD2461 Combined with Valproic Acid Exerts Mild Antagonistic Effects in Hela Cells
    Saman Sargazi et al, 2018, Gene Cell Tissue CrossRef
  8. Neuronal-Specific Deficiency of the Splicing Factor Tra2b Causes Apoptosis in Neurogenic Areas of the Developing Mouse Brain
    Markus Storbeck et al, 2014, PLoS ONE CrossRef
  9. Inflammation and tuberculosis: host-directed therapies
    A. Zumla et al, 2015, J Intern Med CrossRef
  10. Valproic acid protects septic mice from renal injury by reducing the inflammatory response
    Qiang Zheng et al, 2014, Journal of Surgical Research CrossRef
  11. Histone deacetylase inhibitory effect of Brazilian propolis and its association with the antitumor effect in Neuro2a cells
    Shinobu Ishiai et al, 2014, Food Sci Nutr CrossRef
  12. Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway
    Dominique Bollino et al, 2015, J. Neurochem. CrossRef
  13. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs
    Ina Patties et al, 2016, J Exp Clin Cancer Res CrossRef
  14. A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations
    Christoph Thiel et al, 2017, PLoS Comput Biol CrossRef
  15. Sodium Valproate, a Histone Deacetylase Inhibitor, Provokes Reactive Oxygen Species–Mediated Cytotoxicity in Human Hepatocellular Carcinoma Cells
    Prabakaran Rithanya et al, 2020, J Gastrointest Canc CrossRef
  16. l-Cysteine decorated nanoscale metal–organic frameworks delivering valproic acid/cisplatin for drug-resistant lung cancer therapy
    Wenna Guo et al, 2020, Chem. Commun. CrossRef
  17. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death
    Hyun Kyung Park et al, 2020, IJMS CrossRef
  18. Valproic acid promotes radiosensitization in meningioma stem-like cells
    Hsin-Ying Clair Chiou et al, 2015, Oncotarget CrossRef
  19. Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis
    Yusuke Chihara et al, 2020, Int J Oncol CrossRef
  20. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
    Omid Kooshkaki et al, 2020, IJMS CrossRef
  21. Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
    Natália Lourenço de Freitas et al, 2021, Front. Cell Dev. Biol. CrossRef
  22. Synthesis, characterization, toxicity and morphology assessments of newly prepared microemulsion systems for delivery of valproic acid
    Saman Sargazi et al, 2021, Journal of Molecular Liquids CrossRef
  23. HDAC4 Inhibitors with Cyclic Linker and Non‐hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in   vitro Cytotoxicity evaluation.
    Kalpana Tilekar et al, 2021, ChemistrySelect CrossRef
  24. Anti-proliferative and Apoptotic Effects of Valproic Acid on HeLa Cells
    Nasser Hashemi et al, 2022, Int J Cancer Manag CrossRef
  25. C/EBPα regulates the fate of bone marrow mesenchymal stem cells and steroid-induced avascular necrosis of the femoral head by targeting the PPARγ signalling pathway
    Ping Duan et al, 2022, Stem Cell Res Ther CrossRef
  26. From HDAC to Voltage-Gated Ion Channels: What’s Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer
    Michele Pellegrino et al, 2022, Cancers CrossRef
  27. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells
    Marina Amorim Rocha et al, 2023, CMP CrossRef
  28. The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
    Iason Psilopatis et al, 2023, Cancers CrossRef
  29. Valproate Mediated Proteasome Dysfunctions Induce Apoptosis
    Sumit Kinger et al, 2024, Advanced Therapeutics CrossRef